1. Rebound growth of hepatic colorectal metastases after neo-adjuvant chemotherapy: effect on survival after resection.
- Author
-
Lim E, Wiggans MG, Shahtahmassebi G, Aroori S, Bowles MJ, Briggs CD, and Stell DA
- Subjects
- Adult, Aged, Aged, 80 and over, Chemotherapy, Adjuvant, Colorectal Neoplasms mortality, Databases, Factual, Disease Progression, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Liver Neoplasms diagnostic imaging, Liver Neoplasms mortality, Male, Middle Aged, Risk Factors, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Tumor Burden, Colorectal Neoplasms pathology, Hepatectomy adverse effects, Hepatectomy mortality, Liver Neoplasms secondary, Liver Neoplasms therapy, Neoadjuvant Therapy adverse effects, Neoadjuvant Therapy mortality
- Abstract
Background: A period of recovery is commonly allowed between completion of chemotherapy for colorectal liver metastases (CRLM) and resection, during which tumour progression may occur. The study-aim is to assess the growth of CRLM in this interval and association with outcome., Method: Data on 146 patients were analysed. Change in tumour size was assessed by comparing size determined by imaging performed on completion of chemotherapy with that determined by examination of the resected specimen, categorised by RECIST criteria., Results: In the interval before surgery sixteen patients (11%) fulfilled criteria for partial response (PR), 48 (33%) had stable disease (SD) and 82 (56%) had progressive disease (PD). Among patients with PD following chemotherapy the median disease-free survival of patients who initially responded (26 months) was longer than in those who initially had stable disease (7 months) (P = 0.002). No association was noted between rate of tumour growth after completion of chemotherapy and disease-free survival., Conclusion: Change in tumour size after completion of chemotherapy is variable and can be rapid, especially in patients who initially respond to treatment. However, disease-free survival is determined by tumour behaviour during treatment and not by change in size after completion of chemotherapy., (Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF